These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

129 related items for PubMed ID: 21195709

  • 1. Reversal effect of Dioscin on multidrug resistance in human hepatoma HepG2/adriamycin cells.
    Sun BT, Zheng LH, Bao YL, Yu CL, Wu Y, Meng XY, Li YX.
    Eur J Pharmacol; 2011 Mar 05; 654(2):129-34. PubMed ID: 21195709
    [Abstract] [Full Text] [Related]

  • 2. Cantharidin reverses multidrug resistance of human hepatoma HepG2/ADM cells via down-regulation of P-glycoprotein expression.
    Zheng LH, Bao YL, Wu Y, Yu CL, Meng X, Li YX.
    Cancer Lett; 2008 Dec 08; 272(1):102-9. PubMed ID: 18703276
    [Abstract] [Full Text] [Related]

  • 3. Effects of multidrug resistance, antisense RNA on the chemosensitivity of hepatocellular carcinoma cells.
    Li B, Ye T, Zhao L, Li DH, Gou XH, Zhao LY, Han L, Chen L, Yan LN, Gong JP.
    Hepatobiliary Pancreat Dis Int; 2006 Nov 08; 5(4):552-9. PubMed ID: 17085341
    [Abstract] [Full Text] [Related]

  • 4. Establishment of hepatocellular carcinoma multidrug resistant monoclone cell line HepG2/mdr1.
    Chen YB, Yan ML, Gong JP, Xia RP, Liu LX, Li N, Lu SC, Zhang JG, Zeng DB, Xie JG, Yang JY, Yan LN.
    Chin Med J (Engl); 2007 Apr 20; 120(8):703-7. PubMed ID: 17517188
    [Abstract] [Full Text] [Related]

  • 5. Icaritin reverses multidrug resistance of HepG2/ADR human hepatoma cells via downregulation of MDR1 and P‑glycoprotein expression.
    Sun L, Chen W, Qu L, Wu J, Si J.
    Mol Med Rep; 2013 Dec 20; 8(6):1883-7. PubMed ID: 24145579
    [Abstract] [Full Text] [Related]

  • 6. Riboregulator H19 induction of MDR1-associated drug resistance in human hepatocellular carcinoma cells.
    Tsang WP, Kwok TT.
    Oncogene; 2007 Jul 19; 26(33):4877-81. PubMed ID: 17297456
    [Abstract] [Full Text] [Related]

  • 7. Reversal of drug resistance in breast carcinoma cells by anti-mdr1 ribozyme regulated by the tumor-specific MUC-1 promoter.
    Gao P, Zhou GY, Guo LL, Zhang QH, Zhen JH, Fang AJ, Lin XY.
    Cancer Lett; 2007 Oct 18; 256(1):81-9. PubMed ID: 17637500
    [Abstract] [Full Text] [Related]

  • 8. Effects of celecoxib on the reversal of multidrug resistance in human gastric carcinoma by downregulation of the expression and activity of P-glycoprotein.
    Huang L, Wang C, Zheng W, Liu R, Yang J, Tang C.
    Anticancer Drugs; 2007 Oct 18; 18(9):1075-80. PubMed ID: 17704658
    [Abstract] [Full Text] [Related]

  • 9. Evaluation of hydro-alcoholic extract of Eclipta alba for its multidrug resistance reversal potential: an in vitro study.
    Chaudhary H, Jena PK, Seshadri S.
    Nutr Cancer; 2013 Oct 18; 65(5):775-80. PubMed ID: 23859045
    [Abstract] [Full Text] [Related]

  • 10. Synergism of hydroxyapatite nanoparticles and recombinant mutant human tumour necrosis factor-alpha in chemotherapy of multidrug-resistant hepatocellular carcinoma.
    Li G, Dong S, Qu J, Sun Z, Huang Z, Ye L, Liang H, Ai X, Zhang W, Chen X.
    Liver Int; 2010 Apr 18; 30(4):585-92. PubMed ID: 19780956
    [Abstract] [Full Text] [Related]

  • 11. Dioscin restores the activity of the anticancer agent adriamycin in multidrug-resistant human leukemia K562/adriamycin cells by down-regulating MDR1 via a mechanism involving NF-κB signaling inhibition.
    Wang L, Meng Q, Wang C, Liu Q, Peng J, Huo X, Sun H, Ma X, Liu K.
    J Nat Prod; 2013 May 24; 76(5):909-14. PubMed ID: 23621869
    [Abstract] [Full Text] [Related]

  • 12. MicroRNA-122 sensitizes HCC cancer cells to adriamycin and vincristine through modulating expression of MDR and inducing cell cycle arrest.
    Xu Y, Xia F, Ma L, Shan J, Shen J, Yang Z, Liu J, Cui Y, Bian X, Bie P, Qian C.
    Cancer Lett; 2011 Nov 28; 310(2):160-9. PubMed ID: 21802841
    [Abstract] [Full Text] [Related]

  • 13. C-Phycocyanin inhibits MDR1 through reactive oxygen species and cyclooxygenase-2 mediated pathways in human hepatocellular carcinoma cell line.
    Nishanth RP, Ramakrishna BS, Jyotsna RG, Roy KR, Reddy GV, Reddy PK, Reddanna P.
    Eur J Pharmacol; 2010 Dec 15; 649(1-3):74-83. PubMed ID: 20858479
    [Abstract] [Full Text] [Related]

  • 14. Reversal of multidrug resistance by two nordihydroguaiaretic acid derivatives, M4N and maltose-M3N, and their use in combination with doxorubicin or paclitaxel.
    Chang CC, Liang YC, Klutz A, Hsu CI, Lin CF, Mold DE, Chou TC, Lee YC, Huang RC.
    Cancer Chemother Pharmacol; 2006 Nov 15; 58(5):640-53. PubMed ID: 16544145
    [Abstract] [Full Text] [Related]

  • 15. Chemoprotection effect of retroviral vector encoding multidrug resistance 1 gene to allow intensified chemotherapy in vivo.
    Guo CB, Li YC, Jin XQ.
    Cancer Chemother Pharmacol; 2006 Jul 15; 58(1):40-9. PubMed ID: 16284790
    [Abstract] [Full Text] [Related]

  • 16. Reversal of P-glycoprotein-mediated multidrug resistance in vitro by milbemycin compounds in adriamycin-resistant human breast carcinoma (MCF-7/adr) cells.
    Xiang W, Gao A, Liang H, Li C, Gao J, Wang Q, Shuang B, Zhang J, Yan Y, Wang X.
    Toxicol In Vitro; 2010 Sep 15; 24(6):1474-81. PubMed ID: 20656007
    [Abstract] [Full Text] [Related]

  • 17. Chemoprotection effect of multidrug resistance 1 (MDR1) gene transfer to hematopoietic progenitor cells and engrafted in mice with cancer allows intensified chemotherapy.
    Guo C, Jin X.
    Cancer Invest; 2006 Nov 15; 24(7):659-68. PubMed ID: 17118775
    [Abstract] [Full Text] [Related]

  • 18. [Reversal of multidrug resistance gene MDR1 and MRP of drug-resistant human hepatocellular carcinoma cells SMMC-7721/ADM with antisense phosphorothioate oligonucleotides].
    Luo HY, Yang JY, Liu ZM, Lin QY, Yan LN.
    Zhonghua Gan Zang Bing Za Zhi; 2004 Feb 15; 12(2):85-7. PubMed ID: 14980107
    [Abstract] [Full Text] [Related]

  • 19. Reversal effect of isotetrandrine, an isoquinoline alkaloid extracted from Caulis Mahoniae, on P-glycoprotein-mediated doxorubicin-resistance in human breast cancer (MCF-7/DOX) cells.
    Wang TX, Yang XH.
    Yao Xue Xue Bao; 2008 May 15; 43(5):461-6. PubMed ID: 18717331
    [Abstract] [Full Text] [Related]

  • 20. Expression of CD147 mediates tumor cells invasion and multidrug resistance in hepatocellular carcinoma.
    Jia L, Xu H, Zhao Y, Jiang L, Yu J, Zhang J.
    Cancer Invest; 2008 Dec 15; 26(10):977-83. PubMed ID: 19093255
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.